BioMarin Pharmaceutical, Inc. (BMRN)
55.50
-1.74
(-3.04%)
USD |
NASDAQ |
Apr 02, 16:00
55.60
+0.10
(+0.18%)
After-Hours: 20:00
BioMarin Pharmaceutical EPS Diluted (Quarterly) : -0.2423 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| Ionis Pharmaceuticals, Inc. | -1.414 |
| Mirum Pharmaceuticals, Inc. | -0.111 |
| Hims & Hers Health, Inc. | 0.0893 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.57M |
| Revenue (Quarterly) | 895.02M |
| Total Expenses (Quarterly) | 941.59M |
| Enterprise Value | 9.756B |
| Gross Profit Margin (Quarterly) | 68.65% |
| Profit Margin (Quarterly) | -5.20% |
| Earnings Yield | 3.21% |
| Operating Earnings Yield | 7.57% |
| Normalized Earnings Yield | 5.738 |